An investigation of the effects of thiamine in the experimental diabetic rat brain tissue

dc.contributor.authorAkalin, Yahya
dc.contributor.authorBulut, Serpil
dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorDemir, Caner F.
dc.contributor.authorTasci, Irem
dc.date.accessioned2026-08-12T16:42:22Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractBACKGROUND: Thiamine is necessary in the catabolism of carbohydrates and most amino acids. In experimental studies, it was observed that thiamine has antioxidant properties. In this study, the protective effects of thiamine were investigated on the apoptotic changes of brain tissue in a diabetic rat model induced by streptozotocin. METHODS: Twenty-one adult male Wistar albino rats were divided into three groups (N.=7 each). Group I was used as control. Rats in group II (DM) and group III (DM-T) were exposed intraperitoneal streptozotocin (50 mg/kg) to establish diabetes mellitus rat model. After confirmed of experimental diabetes mellitus, diabetic animals in DM group were received just standard chow and water, whereas diabetic rats of DM-T group were received thiamine (25 mg/kg/day, oral) for six weeks. After treatment duration, all of rats were decapitated. To observe the apoptotic changes TUNEL and immunohistochemical (Bax) techniques were used. malondialdehyde (MA) levels were measured in brain tissue. RESULTS: In immunohistochemistry and TUNEL staining; according to the group I and group III Bax immunoreactivity and apoptotic cells were increased in group II. MDA levels increased significantly in DM group compared to group I, also reduced significantly DM group compared DM-T. CONCLUSIONS: It was observed that thiamine has protective effects against DM induced apoptotic changes in the brain tissues. To prevent DM induced cerebral complications, thiamine treatment may be useful.
dc.description.sponsorshipFirat University
dc.description.sponsorshipThis study was supported by a grant from Firat University.
dc.identifier.doi10.23736/S0393-3660.19.04147-0
dc.identifier.endpage511
dc.identifier.issn0393-3660
dc.identifier.issn1827-1812
dc.identifier.issue9
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.scopus2-s2.0-85094841499
dc.identifier.scopusqualityQ4
dc.identifier.startpage505
dc.identifier.urihttps://doi.org/10.23736/S0393-3660.19.04147-0
dc.identifier.urihttps://hdl.handle.net/11508/46236
dc.identifier.volume179
dc.identifier.wosWOS:000581713300003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherEdizioni Minerva Medica
dc.relation.ispartofGazzetta Medica Italiana Archivio per le Scienze Mediche
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectThiamine
dc.subjectDiabetes mellitus
dc.subjectApoptosis
dc.subjectMalondialdehyde
dc.titleAn investigation of the effects of thiamine in the experimental diabetic rat brain tissue
dc.typeArticle

Dosyalar